Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department

Overview of attention for article published in BMC Health Services Research, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 tweeter

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Twitter Dimensions citations

So far, Dimensions has found 8 publications that cite this research output.

8

The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.

Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective

Article in The European Journal of Health Economics (February 2022)

Expediting Discharge in Hospitalized, Adult Patients with Skin and Soft Tissue Infections Who Received Empiric Vancomycin Therapy with Oritavancin: Description of Findings from an Institutional Pathway

Article in Drugs - Real World Outcomes (June 2020)

Early Directed Oritavancin Therapy in the Emergency Department May Lead to Hospital Avoidance Compared to Standard Treatment for Acute Bacterial Skin and Skin Structure Infections: A Real-World Retrospective Analysis

Article in Drugs - Real World Outcomes (June 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.